Type : Research & Development – CRO.
Domains : Biotransformations of Xenobiotics and studies of residues (pharmaceutical compounds, pesticides, chemicals) in animal, soil, plant and human.
Activities : Pharmacokinetics, toxicokinetics, metabolism, distribution, excretion, residues.
Methods : HPLC, LC-MS-MS, RIA, EIA, cryosection, image analysis.
Tracers : Use of radiolabelled isotopes and stable isotopes.

Immunoanalysis and Biomarkers Hypertension Chronobiology Fertility Neurotransmitters Diabetes Inflammation	Bioanalysis Extraction disk plate 96-wells. LC/MS-MS LC/ED, UV, Fluo, RA Parent compound and metabolites. Structural identification MS NMR. Protein binding. Clinical Monitoring Various phases	ADME and CULEX® Automated blood sampling. Hands off dosing via IV, gastric, duodenum. Mass balance U/F/CO2 Rat, dog, human.
Metabolism CYP involvement CYP induction CYP inhibition Drug-drug interactions In vitro => in vivo Rat, Dog, Monkey => Human		Image analysis Quantitative whole body tissue distribution : QRLG Blood-brain barrier transfer Transplacental passage Skin permeation Melanin affinity